Inventor
FAHAR MERCHANT
Inventor
CA
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C12NMicroorganisms or enzymes18%
Y02ATechnologies for adaptation to climate change9%
A01KAnimal husbandry3%
PatentTitleYear
12,590,133IL-13/IL-4 superkines: immune cell targeting constructs and methods of use thereof202612,503,496Interleukin-4 receptor-binding fusion proteins and uses thereof202512,404,497Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof202512,338,269IL-2 superagonists in combination with anti-PD-1 antibodies202512,274,735IL-4-fusion formulations for treatment of central nervous system (CNS) tumors202511,680,090Interleukin-2 fusion proteins and uses thereof202311,542,312IL-2 superagonists in combination with anti-PD-1 antibodies202311,352,402Interleukin-4 receptor-binding fusion proteins and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MEDICENNA THERAPEUTICS INC (8)· patent assignee history
2022–2026Based in CA· patent location history
2025Patents assigned to US HEALTH (1)· patent assignee history
2026Patents assigned to UNIV LELAND STANFORD JUNIOR (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MEDICENNA THERAPEUTICS INC | 8 | 2022–2026 |
| UNIV LELAND STANFORD JUNIOR | 1 | 2026 |
| US HEALTH | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CA | 8 | 2022–2026 |